A UCLA student is suing multiple California health care providers and hospitals for medical negligence, alleging she was ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...

SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 With the growing popularity of weight loss drugs like Ozempic, Wegovyn, ...

Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...

Hims & Hers faces regulatory hurdles but shows strong business growth. Find out why HIMS stock is a "Hold" despite setbacks ...

Vivani Medical (VANI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 20. Analyst Naz ...

As the festive season approaches, experts have a warning for those taking prescription GLP-1 receptor agonist drugs.

GLP-1 drugs are remarkably effective at addressing obesity, cardiovascular, and metabolic conditions, but investigators ...

Hims & Hers Health (HIMS) shares tumble after the US Food and Drug Administration (FDA) announced that the shortage in Eli ...

The marketing initiative touts the protein and fiber content, which appeals to consumers taking weight-loss medications such ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...